Pcsa stock.

Following the reverse stock split, the Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “PCSA” with the new CUSIP number 74275C304. The reverse stock split is intended for the Company to regain compliance with the minimum bid price requirement of $1.00 per share of common stock …PCSA - Processa Pharmaceuticals Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. ... Processa Pharmaceuticals stock price target cut to $2 from $5 at Maxim Group MarketWatch. Thursday, January 12, 2023. 07:38 AM ET. Processa Pharmaceuticals stock price …A high-level overview of Processa Pharmaceuticals, Inc. (PCSA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Processa Pharmaceuticals, Inc. Announces $6.25 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules. (GlobeNewswire) Jan-04-23 08:30AM. Processa Pharmaceuticals To Present an Update on Its Future Therapeutic Focus and Strategy at the Biotech Showcase on January 11, 2023.1 day ago · The stock of Processa Pharmaceuticals Inc (PCSA) has seen a -18.55% decrease in the past week, with a 31.17% gain in the past month, and a -14.04% decrease in the past quarter. The volatility ratio for the week is 10.23%, and the volatility levels for the past 30 days are at 10.65% for PCSA.

Stock Price Forecast. The 2 analysts with 12-month price forecasts for PCSA stock have an average target of 6.00, with a low estimate of 4.00 and a high estimate of 8.00. The average target predicts an increase of 187.08% from the current stock price of 2.09.

PCSA Stock Price Chart Interactive Chart > Processa Pharmaceuticals, Inc. (PCSA) Company Bio. Processa Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company focuses on development of drug products that are intended to improve the survival and quality of life for patients who have unmet medical need. Processa Pharmaceuticals …

A high-level overview of Processa Pharmaceuticals, Inc. (PCSA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Receive PCSA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Processa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PCSA) was last updated on 4/26/2024 by MarketBeat.com StaffFollowing the reverse stock split, the Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “PCSA” with the new CUSIP number 74275C304.What is Processa Pharmaceuticals's stock symbol? The ticker symbol for Processa Pharmaceuticals is PCSA. What is the current stock price of Processa ...Find the latest historical data for Processa Pharmaceuticals, Inc. Common Stock (PCSA) at Nasdaq.com.

Discover historical prices for PCSA stock on Yahoo Finance. View daily, weekly or monthly format back to when Processa Pharmaceuticals, Inc. stock was issued.

Co-Founder recently bought US$51k worth of stock Feb 10. Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule Feb 07. Processa Pharmaceuticals, Inc. has completed a Follow-on Equity Offering in the amount of $6.99989 million. ... PCSA) Cash Burn Rate Jan 20. Processa Pharmaceuticals …

5.8400. 5.2000. 5.2400. 5.2400. 2,125. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or capital gain distributions. Discover historical prices for PCSA stock on Yahoo Finance. View daily, weekly or monthly formats back to when Processa Pharmaceuticals, Inc. stock was issued.Processa (PCSA) stock rallied 25% after the company said it plans to expand development of NGC-Cap into breast cancer to provide a more efficient pathway to potential FDA approval.The Company’s common stock will begin trading on a reverse stock split-adjusted basis at the opening of the market on Monday, January 22, 2024. Following the reverse stock split, the Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “PCSA” with the new CUSIP number 74275C304.Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) announces CEO George Ng's corporate overview presentation at the Biotech Showcase 2024, focusing on developing next-gen chemotherapeutic drugs for cancer patients.4 days ago ... PCSA Stock Earnings: Processa Pharma Reported Results for Q1 2024 · Processa Pharma reported earnings per share of -$1.11. · The company did not ....HANOVER, MD, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces the formation of its …Processa Pharmaceuticals' stock was trading at $6.6920 at the start of the year. Since then, PCSA shares have decreased by 68.8% and is now trading at $2.09. The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.

Get Processa Pharmaceuticals Inc (PCSA.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Processa Pharmaceuticals Inc stock price live, this page displays NASDAQ PCSA stock exchange data. View the PCSA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Processa Pharmaceuticals Inc real time stock price chart below.May 6, 2024 · Rhea-AI Summary. Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) has closed a public offering of 1,555,555 shares of common stock and common warrants, raising $7.0 million in gross proceeds. The offering price per share was $4.50, with the common warrants having an exercise price of $4.50 per share and a term of five years. May 10, 2024 · Price vs Fair Value. View History. PCSA is trading within a range we consider fairly valued. Price. $2.06. May 10, 2024. Fair Value. $3.41. May 10, 2024.

Nasdaq. 16,332.56. –0.10% US 10 Yr. 4.46. +0.24% FTSE 100. 8,313.67. +1.22% Crude Oil. 78.31. –0.09% Gold. 2,323.50. –0.03% Euro. 1.08. –0.02% Pound/Dollar. 1.25. –0.03% Markets. Data. Processa...Processa Pharmaceuticals Inc stock price (PCSA) NASDAQ: PCSA. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Processa Pharmaceuticals Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.

Find the latest Processa Pharmaceuticals, Inc. (PCSA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Find the latest news headlines from Processa Pharmaceuticals, Inc. Common Stock (PCSA) at Nasdaq.com.Processa Pharmaceuticals Inc share price live 1.5566, this page displays NASDAQ PCSA stock exchange data. View the PCSA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Processa Pharmaceuticals Inc real time stock price chart below. You can find more … View the latest Processa Pharmaceuticals Inc. (PCSA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Stock shares do not have an expiration date. There are companies listed on the stock exchanges whose shares have traded for over 100 years. However, there are several circumstances...Following the reverse stock split, the Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “PCSA” with the new CUSIP number 74275C304.PCSA-1, 280 x 220mm PCB Holder. RS Stock No.: 787-0314Brand: ideal-tekManufacturers Part No.Processa Pharmaceuticals Inc stock (PCSA) in USD. 1 PCSA = 2.46 USD. 1 month. 6 months. 1 year. 5 years. Processa Pharmaceuticals Inc stock performance at a glance. Check Processa Pharmaceuticals Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. PCSA Stock …Processa Pharmaceuticals Stock Forecast, PCSA stock price prediction. Price target in 14 days: 2.886 USD. The best long-term & short-term Processa ...Find More Stocks. Use our equities screener to discover other potential opportunities. Find Similar Stocks Find Stocks Similar to PCSA

PCSA. 2.090. -1.88%. Webull offers Processa Pharmaceuticals Inc (PCSA) historical stock prices, in-depth market analysis, NASDAQ: PCSA real-time stock quote data, in-depth charts.

Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price...

Processa Pharmaceuticals ( NASDAQ: PCSA) lost ~16% on Wednesday after the drug developer disclosed feedback it received from the FDA regarding a mid-stage trial for its chemotherapy candidate ...Processa Pharmaceuticals (NASDAQ:PCSA) on Friday priced the public offering of its stock and warrants to raise gross proceeds of up to $7 million.The offering will consist of 1,555,555 shares or ...Future criteria checks 0/6. Processa Pharmaceuticals is forecast to grow earnings and revenue by 36.9% and 63.8% per annum respectively while EPS is expected to grow by 40.2% per annum.PCSA. 2.090. -1.88%. Webull offers Processa Pharmaceuticals Inc (PCSA) historical stock prices, in-depth market analysis, NASDAQ: PCSA real-time stock quote data, in-depth charts.Jan 18, 2024 ... Following the reverse stock split, the Company's common stock will continue to trade on the Nasdaq Capital Market under the symbol “PCSA” with ...HANOVER, MD, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces that Dr. David Young ...Processa Pharmaceuticals stock analysis 2024. View PCSA current price, quote, financial & revenue summaries, forecast, earnings transcripts, and news. ... Tickergate is an advanced stock research & comparison platform for informed data-driven investment decisions. 100% customizable, institutional-grade data, easy to use. Company. About …Processa Pharmaceuticals Stock Forecast, PCSA stock price prediction. Price target in 14 days: 2.886 USD. The best long-term & short-term Processa ...

Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...Jul 11, 2022 ... Bloomberg Markets. 󱢏. Broadcasting & media p... No photo description available. New York Stock Exchange. New York Stock Exc... 󱢏. Financial ...Find the latest Processa Pharmaceuticals, Inc. (PCSA) stock quote, history, news and other vital information to help you with your stock trading and investing.PCSA Earnings Date and Information. Processa Pharmaceuticals last posted its earnings data on March 29th, 2024. The reported ($0.24) EPS for the quarter. Processa Pharmaceuticals has generated ($4.95) earnings per share over the last year ( ($4.95) diluted earnings per share). Earnings for Processa Pharmaceuticals are expected to grow in the ...Instagram:https://instagram. new thermostatiplayer bbcenglish to rusisanplane above me Find the latest Processa Pharmaceuticals, Inc. (PCSA) stock quote, history, news and other vital information to help you with your stock trading and investing.PCSA - Processa Pharmaceuticals Inc Stock Price and Quote. Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. PCSA. Processa … gamechanger log inoxford dictionaries Find the latest Processa Pharmaceuticals, Inc. (PCSA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Mountain. Loading Chart for PCSA. 9/21 12:03 PM. Previous Close 2.1300. Open 2.1100. Bid 2.0500 x 100. Ask 2.1100 x 200. Day's Range 2.0813 - 2.1900. 52 Week Range 1.4000 - 18.0000. Volume... english to rusisan Interactive Chart. Interactive Charts provide the most advanced and flexible platform for analyzing historical data, with over 100 customizable studies, drawing tools, custom spreads and expressions, plus a wide range of visualization tools. While logged into the site, you will see continuous streaming updates to the chart.A high-level overview of Processa Pharmaceuticals, Inc. (PCSA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.